摘要
在我国现行经济新常态的情况下,各个行业的发展都受到了不同程度的影响。在此背景下,医药行业的发展同样受到不小的冲击。文中选取12家上市医药企业2011到2015年的财务数据,从投资者角度考虑,对其各个上市公司基本财务数据的变动情况、盈利能力、偿债能力等方面进行分析并做出评价,在此基础上针对医药行业健康发展提出相关建议。
Under the condition of China＇s current downturn economic,the development of varieties industries has suffered different levels of blow,On this background,the development of the pharmaceutical industry also suffered impact. This paper choose twelve companies data which from 2011 to 2015,and analysis the listed companies basic financial data changes,profitability,solvency and other aspects from investor perspective,besides,give the relevant recommendations about the healthy development of the pharmaceutical industry on the basis of this situation.
出处
《物流工程与管理》
2017年第2期145-146,共2页
Logistics Engineering and Management
关键词
医药行业
财务分析
投资
pharmaceutical industry
financial analysis
investment
